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ABSTRACT
Context: Current review focuses on the importance of pharmaceutical analytical techniques in the diagnosis of diabetes and the study of antidiabetic drugs.
Objective: The main objective of the review is to compile the different analytical tools such as UV-spectroscopy, Fourier-transform infrared (FT-IR), 
nuclear magnetic resonance (NMR), liquid chromatography-mass spectrometry (LC-MS), gas chromatography (GC)-MS, and electrophoresis that are 
used to diagnose diabetes using different analytical methods. It also attempts to provide information on the assay of antidiabetic drugs by various 
analytical techniques and thus helps in the development of novel methods for the study of newer drugs molecules having antidiabetic activity.
Methods: The blood sample is subjected to centrifugation to collect the serum before any analytical estimation of antidiabetic drugs. The different 
types of diabetes were diagnosed using various analytical techniques such as UV-spectroscopy, FT-IR, NMR, LC-MS, GC-MS, and electrophoresis.
Results: Different analytical methods that were reported in the literature, were succinctly discussed about the quantification of various antidiabetic 
drugs. These methods were also employed for the determination of antidiabetic drugs in the research field for the study of actives pharmaceutical 
ingredients, marketing dosage forms, and post-marketed dosage forms.
Conclusion: This review is compiled in such a manner such that it helps the analysts to diagnose diabetes using different analytical techniques and also 
to study various antidiabetic drugs in the pharmaceutical research field. It also attempts to provide information about different active pharmaceutical 
ingredients, marketing dosage forms, and post-marketed dosage forms.
Keywords: Diabetes, Pharmaceutical analysis, Diagnosis, Antidiabetic drugs, UV spectroscopy, Fourier-transform infrared, Nuclear magnetic 
resonance, High-performance liquid chromatography, Electrophoresis.
INTRODUCTION
Diabetes mellitus (DM) is caused due to the insufficient secretion 
of insulin. DM is considered as a metabolic disorder due to the long-
term tissue or organ damage. It may also occur due to the damage of 
kidney or vascular system or nervous system [1]. In diabetes, blood 
sugars levels are increased for a prolonged period due to the group of 
metabolic diseases [2]. Diabetes is also characterized by a reduction 
in the protein, carbohydrate, and fat metabolism due to the insulin 
deficiency, thus causing chronic hyperglycemia [3].
According to the WHO guidelines, diabetes is classified into several 
types.
DM
Regardless of reasons DM is divided into two types.
a. Insulin-dependent DM (IDDM): To control the body metabolism 
insulin is required. Insulin secreted in the body is not sufficient to 
control the metabolism; hence, insulin is administered into the body 
externally to get normal glycemic levels.
b. Non-IDDM: This type of diabetes can be controlled with the help of 
oral hypoglycemic drugs which, in turn, can control blood glucose 
levels.
Impaired glucose tolerance (IGT) or impaired glucose regulation 
and impaired fasting glycemia (IFG)
The terms IGT and IFG, both are different, where IGT measure glucose 
levels in post-prandial state and IFG measures glucose levels in 
fasting conditions. A stage of IGT indicates the progress in the risk of 
diabetes, macrovascular, and cardiovascular disorders. IFG indicates 
cardiovascular disorder. IFG levels are always less than the normal 
glucose levels because it is usually measured under fasting condition [3].
If IFG levels 100–125 mg/dl or 5.6 mmol-6.9 mmol/L and IGT levels are 
in the range of 140–199 mg/dl are considered acceptable [4].
Normoglycemia
Fasting glucose levels around 6 mmol/L are considered as normal 
levels. Such results also may have IGT or normal glucose tolerance. The 
values beyond this level lead to macro- or micro-vascular diseases [3].
Etiological types
Based on a-etiological factors diabetes is divided into the following 
types:
Type-I diabetes
Type-I diabetes is usually progresses due to the dysfunction of β cells 
present in the pancreas, leads to a deficiency in insulin production. 
β-Cells are destroyed by anti-glutamic acid decarboxylase, islet cell or 
insulin antibodies. Due to this condition absolute insulin deficiency 
occurs [3,5].
Type-II diabetes
Insulin resistance and deficiency of relative quantities of insulin are 
characteristic features of Type-II diabetes. Both can be present at a 
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time and either of the conditions predominant clinically. The reason 
for this type is unknown even though this is a common type of 
diabetes [3].
Gestational hyperglycemia
It occurs during the pregnancy and may improve or recover after the 
delivery. Gestational hyperglycemia condition is similar to that of Type-
II diabetes. Gestational diabetes causes health issues in the fetus or 
pregnant women. After the birth, the child may have congenital cardiac 
and central nervous system disorders, malformations of skeletal 
muscle, heavyweight and respiratory distress syndrome. Sometimes 
perinatal death may also occur due to the hyperbilirubinemia [2,3]. In 
the first trimester of pregnancy, the risk of gestational diabetes is very 
much high. In general, the diagnosis of gestational diabetes is carried 
out between 24 and 28 weeks of pregnancy [3].
Complications of diabetes




It also termed as a medical emergency in diabetes, for example, diabetes 
ketoacidosis and hypoglycemia.
Chronic complications
It includes microvascular complications and macrovascular 
complications. It includes hyperglycemia and hypoinsulinemia or other 
metabolic disorders associated with them.
a. Microvascular problems: This also called as microangiopathic. 
This includes diabetes retinopathy, diabetic neuropathy, and some 
diabetic skin problems.
b. Macrovascular problems: This includes hypertension, arteriosclerosis, 
and cerebrovascular disease.
c. Other associated metabolic abnormalities: Other abnormalities 
include hypercholesterolemia.
Signs and symptoms
Polyuria, weight loss, polydipsia, and polyphagia are common 
symptoms of diabetes. Along with this blurry vision, headache, fatigue, 
reduced healing capacity, and itchy skin are also observed. Sometimes 
dehydration may also occur [2].
Prevention
It is always said that prevention is better than cure. Type-II diabetes 
can be prevented by physical exercise, maintaining normal weight, and 
diet regulation. Healthy diet includes rich in whole grain, fiber, good 
fats present in vegetable oils, nuts, and fish. Smoking and consumption 
of alcohol increase the occurrence of diabetes and hence should be 
avoided [2].
Treatment
a. Type-I diabetes: Insulin or semi-synthetic insulin is administered 
according to the weight, age, and sex of the patient.
b. Type-II diabetes: Metformin is the most widely used drug for this 
type of diabetes. Other types of oral hypoglycemic drugs are also 
prescribed depending on the conditions. In addition, angiotensin-
converting enzyme inhibitors can also be used in the treatment of 
this type of diabetes [2].
Treatment
a. Type-I diabetes: Insulin or synthetic insulin is administered 
according to the weight, age, and sex of the patient (Fig. 1).
b. Type-II diabetes: Metformin is the most preferred drug for this type 
of diabetes (Fig. 2). Angiotensin-converting enzyme inhibitors are 
also used for the treatment Type-II diabetes [2,6].
Study of antidiabetic drugs
Study of antidiabetic drugs can be carried out by various analytical 
techniques in the pharmaceutical research field from drug development 
to marketing and post-marketing. Study of active pharmaceutical 
ingredients, dosage forms, impurities, intermediate products, diagnosis 
of diseases, biological samples, and degradation products can also be 
performed. Analytical techniques include titrimetry, spectroscopy, 
chromatography, electrophoresis, and other electrical methods [7].
Pharmaceutical analytical techniques used in the study of drugs.
Titrimetry and electrical methods
Titrimetric methods include acid-base titration, oxidation-reduction, 
complexometry, precipitation titration, non-aqueous titrations, and 
diazotization titration. These methods are conventional methods and 
were used in the analysis in earlier days. Now, they are have been 
replaced by electrical methods such as potentiometry, conductometry, 
and amperometry. Using these methods then there is an improvement 
in the endpoint detection, accuracy, and precision; in addition, it saves 
the labor, cost incurred, and time. Titrimetric methods can also be used 
for the estimation of degradation products [7], for example, metformin 
hydrochloride (non-aqueous titration) [8], tolazamide (non-aqueous 
titration) [9], and pioglitazone-HCl (Acid-base titration) [10].
Chromatographic techniques
Chromatography is an important analytical tool used for the separation 
of compounds according to their affinity toward the stationary phase. 
No single molecule have the same affinity due to difference in their 
molecular structure or composition [11].
Thin-layer chromatography (TLC)
In the TLC method, a thin layer of 0.25 mm thickness solid adsorbents 
acts as a stationary phase. To increase the adherence capacity of 
adsorbent to plate’s binders is mixed with adsorbents as listed in 
Table 1 while preparing the slurry. The plates or sheets used for the 
preparation of TLC plates are made out of glass, plastic, or aluminum. 
Sample molecules are dissolved in suitable solvents, and the sample 
solution is applied to TLC plates with the help of micropipette at the 
bottom of the plate. TLC plate is introduced into the chamber which 
consists of mobile phase usually as a mixture of solvents. Mobile phase 
moves over the plate with the help of capillary action, and as a result, 
separation of molecules occurs according to the affinity.
This method used for the high degree of separation and purification of 
organic and inorganic samples with low cost. It also used for determination 
of impurities [7,11], for example, metformin [12-14], pioglitazone 
hydrochloride [15], glibenclamide, glimepiride [15,16], dasatinib [17], 
chlorpropamide [18], rosiglitazone [19], and nateglinide [14].
High-performance liquid chromatography (HPLC)
HPLC is the most preferred method of analysis in recent times. 
HPLC is a powerful qualitative and quantitative analytical 
technique, which are able to separate similar analytes present 
in the mixtures. Separation of molecules occurs in the column in 
short time under high pressure [7,11]. Simultaneous estimation 
of compounds also possible using HPLC, for example, tolbutamide 
[20], glibenclamide [21,22], glipizide [22], glimepiride [22], 
acarbose [23], miglitol [24], bromocriptine [25], alogliptin 
[26], metformin [26,27], albiglutide [28], liraglutide [29], 
linagliptin [30], saxagliptin [27], sitagliptin [31], nateglinide 
[32,33], exenatide [34], repaglinide [35], dapagliflozin [36], canagliflozin 
[37], gliclazide [38], glyburide [39], chlorpropamide [40], tolbutamide 
[41], rosiglitazone [42], and pioglitazone hydrochloride [43].
Gas chromatography (GC)
GC is used for the separation of volatile compounds. Gas LC plays 
an important role in the analysis of pharmaceutical dosage forms. 
Impurities and residual solvents present in traces amount also detected 
by GC [11], for example, metformin [44] and chlorpropamide [45].
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SPECTROSCOPIC METHODS
Ultraviolet-visible spectroscopy
In UV spectrophotometry, the excitation of electrons present in the 
sample molecules occurs easily by absorption of high energy of light 
in the range of 200–800 nm. The molecules with conjugated pi-
electrons are able to absorb the radiation in this region [11].In this 
type of spectroscopy reflection or transmission properties of molecules 
are used for the quantitative analysis as a function of wavelength, for 
example, glibenclamide [46,47], metformin [8,48], acarbose [49], 
miglitol [49,50], alogliptin [50], linagliptin [51], saxagliptin [52], 
Sitagliptin [53], nateglinide [54], repaglinide [55], dapagliflozin, [56], 
canagliflozin [57], empagliflozin [58], glimepiride [59], glipizide [60], 
and chlorpropamide [61].
Infrared (IR) spectroscopy
Molecules or atoms produce vibrational and rotational excitation 
by absorbing energy radiation in the IR region. The different bands 
produced correspond to characteristic absorption of radiation and 
thus helps to identify different functional groups present in the drug 
molecules. Qualitative, quantitative, multi component analysis and 
simultaneous estimation are possible by using IR spectroscopy [7,11], 
for example, Metformin [48].
Nuclear magnetic resonance (NMR) spectroscopy
An NMR spectrum is produced due to the excitation of spin state of 
molecules in the presence of radio frequency rays. NMR spectroscopy 
is divided into various types such as H1, C13, F19, and P31. This method 
is used for qualitative analysis, to identify the structure of the drug 
molecules present in pharmaceuticals and biological samples. 
Determination of impurity and characterization is also done using NMR 
spectroscopy [7,11], for example, metformin [62].
Fluorimetry
Fluorescence spectroscopy is used for the quantitative analysis of 
drug molecules present in drug products and biological samples. 
This method gives precise and sensitive results [11], for example, 
rosiglitazone maleate [63] and nateglinide [64].
Electrophoresis
Electrophoresis method has become an important technique in 
pharmaceutical analysis. Capillary electrophoresis (CE) is the best 
method to separate charged particles through the capillary tube in the 
presence of an electric field. CE is used for the qualitative and quantitative 
analysis of charged molecules. This method requires small amount of 
sample in aqueous condition. Biopolymers and inorganic ions can be 
separated by CE [7], for example, sitagliptin [65] and metformin [65].
HYPHENATED TECHNIQUES
LC-mass spectrometry (MS)
HPLC connected with MS with various interfaces. Effluent from the column 
of HPLC enters into the MS through the interface. In MS, ions are generated 
and sent to electron multiplier tubes. Ionization occurs using two methods, 
namely Atmospheric pressure chemical ionization and ESI or APESI: 
(Atmospheric pressure) or electrospray ionization. Drugs molecules, 
degradants identification, characterization of impurities, and separation 
of components occur by LC-MS method [7,11], for example, acarbose [66], 
miglitol [24], glimepiride [67], dapagliflozin [68], canagliflozin [69], 
Linagliptin [70], sitagliptin [71], saxagliptin [72], and bromocriptine [73].
Fig. 1: Type-I antidiabetic drugs
Fig. 2: Type-II antidiabetic drugs
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GC-MS
GC connected with MS with various interfaces. Effluent from the 
column of GC enters into the MS through the interface. Identification 
of drug molecules and their degradants, characterization of impurities, 
bioassay, and separation of components can be analyzed using LC-MS 
method, for example, metformin [74].
DIAGNOSIS
Diagnosis of diabetes can be done by determining the blood glucose 
levels. In fasting conditions, the blood glucose level could be >6.7 mmol/L 
or random glucose levels will be more than 10 mmol/L considered as 
diabetes. If there occur any doubts in the diagnosis, glucose tolerance 
test have to be conducted to measure the blood glucose level. Before the 
test, the patient needs to be on fast at least for 10–12 h. During the test, 
the patient is advised to take 75 mg glucose orally and the test will be 
repeated after 2 h. Thus, from the results observed, one can determine 
the glucose tolerance of the patient [5].
In the diagnosis process, glucose levels can be determined using various 
analytical methods.
UV spectroscopy
The glucose level of the blood can be determined by comparison of 
the UV spectrum of normal serum and diabetic blood serum. Diabetes 
leads to changes in the metabolism of fats, carbohydrates, and proteins. 
Blood samples are usually collected from normal and diabetic people, 
and the serum is separated by centrifugation of the blood samples. 
The separated serum will further be diluted with deionized water and 
absorbance of the spectrum will be analyzed [75].
Fourier-transform (FT)-IR
Diabetic conditions induce alterations in the content of macromolecules 
and their concentrations, changes in the structure and size of tissues. 
FT-IR is used to determine these changes. Renal plasma membrane was 
separated, and fats were removed from tissue at 0 to 4°C. In general, 
the tissue will be placed in mannitol and buffer for homogenization. 
After homogenization, the sample will be mixed with calcium chloride 
solution (10 mM) and diluted with buffer and centrifuged for 12 min. 
The sediment separated will be dissolved in buffer solution and 
recentrifuged again. The sediment, thus, obtained will be dissolved in 
the supernatant, and this sample solution will be analyzed using FT-IR 
windows [76].
NMR
Identification of metabolite is usually done using NMR spectroscopy in 
diabetes. The collected urine samples are stored in frozen condition. 
The frozen urine sample is maintained in ice for 30 s, and 500 μL of the 
sample will be mixed with buffer. The NMR spectrum for this sample 
solution will be taken and the spectrum thus obtained will be compared 
with the spectra of normal urine and diabetic patient’s urine [77].
Gel electrophoresis
Type-I diabetes affects the function of the salivary gland. Protein 
modification in the saliva indicates Type-I diabetes. After 2 h of 
breakfast make the subject to rinse mouth with water and paraffin has 
to be chewed. The saliva was collected for 5 min in a tube containing 
protease inhibitor, and it is stored at −20°C. The sample solution was 
applied to the general the gel electrophoresis strips were applied with 
the sample solution and allow to equilibrate in buffer solution for 
15 min. A constant voltage is applied to the strips, and the proteins 
are allowed proteins to separate. Gel images are digitalized. The 
comparison of healthy subject saliva protein with diseased subject 
saliva can be helpful in the determination of Type-I diabetes [78].
LC-MS and GC-MS
For carrying out the analysis, a 20 mL of the antecubital venous blood 
sample is collected and processed at 80°C for 6 h to collect the serum 
and is allowed to stand overnight at 4°C to achieve metabolic profiling. 
These samples are diluted to get 30 μg/mL. The samples were added 
with internal standard and centrifuged for 10 min. The supernatant 
was used for metabolite profiling using LC-MS or GC-MS method. The 
presence of amino acids such as leucine, isoleucine, and valine, free fatty 
acids such as palmitic acid and stearic acid and lysophosphatidylinositol 
confirms the occurrence of the diabetic condition [79].
In recent times HbA1c, the glycated hemoglobin has been considered 
as an important marker for the diagnosis of diabetes. Usually, HbA1c 
analytical methods are in general based on the differences in charge 
or structure. The different analytical techniques include ion-exchange 
chromatography, CE, affinity chromatography, and immunoassay. 
Other analytical methods include immunoturbidimetry and ion-
exchange HPLC. Among these methods, HbA1c measured using HPLC 
was significantly higher than compared to other immunoturbidimetric 
methods [80].
CONCLUSION
The present review discusses the types of diabetes and various 
analytical methods used for the diagnosis of diabetes and to study the 
different antidiabetic drugs in a comprehensive manner. This will help 
the future researchers about the different analytical methods that are 
available for the diagnosis of diabetes and the assay of antidiabetic 
drugs and thus helps in the development of novel methods for the study 
of antidiabetic newer drugs molecules.
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